Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Is there mush-room to improve the environmental sustainability of psilocybin production?

Luke Lanham, Alistair R. McTaggart, James R. Falconer

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (163)

  1. Optimized psilocybin production in tryptophan catabolism-repressed fungi. 2024-11-01 · Expand citations
  2. Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms. 2024-10-01 · Expand citations
  3. Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS) 2024-03-01 · Expand citations
  4. Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry 2024-03-01 · Expand citations
  5. Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry 2024-02-01 · Expand citations
  6. Psychedelic-like Activity of Norpsilocin Analogues. 2024-01-17 · Expand citations
  7. A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond. 2023-12-01 · Expand citations
  8. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. 2023-06-01 · Expand citations
  9. The evolution and ecology of psilocybin in nature. 2023-06-01 · Expand citations
  10. Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. 2023-05-01 · Expand citations
  11. Microdosing psilocybin for chronic pain: a case series. 2023-04-01 · Expand citations
  12. A Proposal to Study the Safety and Efficacy of in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder. 2023-01-01 · Expand citations
  13. Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial. 2022-12-01 · Expand citations
  14. Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids. 2022-11-15 · Expand citations
  15. Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. 2022-11-11 · Expand citations
  16. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
  17. Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. 2022-11-01 · Expand citations
  18. Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. 2022-10-01 · Expand citations
  19. A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms 2022-09-01 · Expand citations
  20. Genetic Survey of Psilocybe Natural Products. 2022-07-19 · Expand citations
  21. Psychedelics in the treatment of unipolar and bipolar depression. 2022-07-05 · Expand citations
  22. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. 2022-07-01 · Expand citations
  23. Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats. 2022-06-01 · Expand citations
  24. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. 2022-02-01 · Expand citations
  25. Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects 2022-01-01 · Expand citations
  26. Psilocybin Conspectus: Status, Production Methods, and Considerations. 2022-01-01 · Expand citations
  27. Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report. 2022-01-01 · Expand citations
  28. Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors. 2021-11-24 · Expand citations
  29. Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization 2021-08-19 · Expand citations
  30. The Therapeutic Potential of Psilocybin. 2021-05-15 · Expand citations
  31. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
  32. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. 2021-04-27 · Expand citations
  33. Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity. 2021-04-23 · Expand citations
  34. Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
  35. Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer. 2021-04-09 · Expand citations
  36. Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. 2021-04-01 · Expand citations
  37. Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis. 2021-02-01 · Expand citations
  38. Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. 2021-01-01 · Expand citations
  39. Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products. 2021-01-01 · Expand citations
  40. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. 2020-10-01 · Expand citations
  41. Psilocybin: from ancient magic to modern medicine. 2020-10-01 · Expand citations
  42. Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin 2020-07-14 · Expand citations
  43. Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin. 2020-07-02 · Expand citations
  44. Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives. 2020-07-01 · Expand citations
  45. Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin. 2020-02-28 · Expand citations
  46. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. 2020-02-01 · Expand citations
  47. Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms. 2020-01-13 · Expand citations
  48. An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin 2020-01-08 · Expand citations
  49. In vivo production of psilocybin in E. coli. 2019-12-01 · Expand citations
  50. Production Options for Psilocybin: Making of the Magic. 2019-01-18 · Expand citations
  51. DARK Classics in Chemical Neuroscience: Psilocybin. 2018-10-17 · Expand citations
  52. Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi. 2018-07-01 · Expand citations
  53. Horizontal gene cluster transfer increased hallucinogenic mushroom diversity. 2018-04-01 · Expand citations
  54. Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF). 2018-04-01 · Expand citations
  55. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
  56. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. 2017-12-01 · Expand citations
  57. Enzymatic Synthesis of Psilocybin. 2017-09-25 · Expand citations
  58. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. 2017-07-01 · Expand citations
  59. Long-term follow-up of psilocybin-facilitated smoking cessation. 2017-01-01 · Expand citations
  60. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  61. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  62. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  63. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  64. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. 2014-01-01 · Expand citations
  65. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  66. Effects of Psilocybe argentipes on marble-burying behavior in mice. 2009-08-01 · Expand citations
  67. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  68. Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom” 2003-06-01 · Expand citations
  69. The pharmacology of psilocybin. 2002-10-01 · Expand citations
  70. ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin. 1999-08-17 · Expand citations
  71. Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe. 1989-01-01 · Expand citations
  72. Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis. 1968-10-01 · Expand citations
  73. A biosynthetic sequence from tryptophan to psilocybin. 1968-02-01 · Expand citations
  74. OpenAlex W1464659592
  75. OpenAlex W1968667830
  76. OpenAlex W1975957241
  77. OpenAlex W1981437229
  78. OpenAlex W1993641119
  79. OpenAlex W1997859062
  80. OpenAlex W2016520612
  81. OpenAlex W2022636307
  82. OpenAlex W2030173780
  83. OpenAlex W2030483472
  84. OpenAlex W2031598813
  85. OpenAlex W2038441253
  86. OpenAlex W2049277670
  87. OpenAlex W2053973453
  88. OpenAlex W2086505293
  89. OpenAlex W2087113406
  90. OpenAlex W2094925654
  91. OpenAlex W2099103834
  92. OpenAlex W2115694296
  93. OpenAlex W2120311150
  94. OpenAlex W2135446583
  95. OpenAlex W2138043846
  96. OpenAlex W2151999697
  97. OpenAlex W2167127786
  98. OpenAlex W2327487399
  99. OpenAlex W2474747178
  100. OpenAlex W2610144880
  101. OpenAlex W2734702968
  102. OpenAlex W2753941774
  103. OpenAlex W2782017479
  104. OpenAlex W2888020968
  105. OpenAlex W2916439545
  106. OpenAlex W2945469156
  107. OpenAlex W2946626514
  108. OpenAlex W2947980067
  109. OpenAlex W2948339708
  110. OpenAlex W2953198950
  111. OpenAlex W2980318866
  112. OpenAlex W2988070888
  113. OpenAlex W2996283745
  114. OpenAlex W3086604595
  115. OpenAlex W3089717395
  116. OpenAlex W3093333922
  117. OpenAlex W3102797755
  118. OpenAlex W3129492882
  119. OpenAlex W3133345803
  120. OpenAlex W3138784859
  121. OpenAlex W3145800758
  122. OpenAlex W3176998857
  123. OpenAlex W3183471034
  124. OpenAlex W3200757480
  125. OpenAlex W4200598859
  126. OpenAlex W4206830781
  127. OpenAlex W4220686515
  128. OpenAlex W4220745083
  129. OpenAlex W4220928043
  130. OpenAlex W4226309167
  131. OpenAlex W4249196607
  132. OpenAlex W4285087944
  133. OpenAlex W4308922649
  134. OpenAlex W4312155880
  135. OpenAlex W4313414122
  136. OpenAlex W4313595026
  137. OpenAlex W4313648903
  138. OpenAlex W4317568202
  139. OpenAlex W4382517556
  140. OpenAlex W4384827066
  141. OpenAlex W4386964417
  142. OpenAlex W4387523834
  143. OpenAlex W4387848524
  144. OpenAlex W4390725475
  145. OpenAlex W4392468144
  146. OpenAlex W4392731282
  147. OpenAlex W4395685207
  148. OpenAlex W4396610213
  149. OpenAlex W4396946392
  150. OpenAlex W4397009980
  151. OpenAlex W642244509
  152. OpenAlex W6620936115
  153. OpenAlex W6762783394
  154. OpenAlex W6762947085
  155. OpenAlex W6804133653
  156. OpenAlex W6805085006
  157. OpenAlex W6810004557
  158. OpenAlex W6849281193
  159. OpenAlex W6849308168
  160. OpenAlex W6854314740
  161. OpenAlex W6862692273
  162. OpenAlex W6866232834
  163. OpenAlex W6938913044

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.